mk-0893 and Diabetes-Mellitus

A novel series of glucagon receptor antagonists has been discovered. These pyrazole ethers and aminopyrazoles have lower molecular weight and increased polarity such that the molecules fall into better drug-like property space. This work has culminated in compounds 44 and 50 that were shown to have good pharmacokinetic attributes in dog, in contrast to rats, in which clearance was high; and compound 49, which demonstrated a dose-dependent reduction in glucose excursion in a rat glucagon challenge experiment.

Topics: Animals; Chemistry, Pharmaceutical; Diabetes Mellitus; Dogs; Dose-Response Relationship, Drug; Drug Design; Ether; Glucagon; Glucose; Humans; Kinetics; Models, Chemical; Molecular Weight; Pyrazoles; Rats; Receptors, Glucagon; Temperature